An upregulation of KLF4, a driver of CCM pathogenesis in mutant ECs, leads to the upregulation of the anticoagulant factors thrombomodulin (TM) and endothelial NO synthase (eNOS) [68]. The gene discussed is THBD; the disease is cerebral cavernous malformation.